Humanized anti-CXCR5 antibodies, derivatives thereof and their use
US9228019B2 · kind B2 · utility
0Cited by
72References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 11, 2013 |
| Grant date | Jan 5, 2016 |
| Priority date | — |
| Expiry date | Mar 11, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to humanized antibodies that specifically bind to CXCR5 and can, for example, inhibit CXCR5 function. The invention also includes uses of the antibodies to treat or prevent CXCR5 related diseases or disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.